Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Anticoagulation vs Standard Care in Hospitalized COVID-19 Patients (RAPID COVID COAG)
NCT04362085Phase 3Completed
- Sponsor
- Unity Health Toronto
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of low molecular weight heparin calcium, heparin in coronavirus disease 2019 (COVID-19), sponsored by Unity Health Toronto. Started May 2020; status: completed.
02
Drugs
low molecular weight heparin calciumheparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04362085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04362085.